𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cortical myoclonus in Janz syndrome

✍ Scribed by F Panzica; G Rubboli; S Franceschetti; G Avanzini; S Meletti; A Pozzi; C.A Tassinari


Book ID
119605973
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
908 KB
Volume
112
Category
Article
ISSN
1388-2457

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Cortical myoclonus in angelman syndrome
✍ Dr. Renzo Guerrini; Paolo Bonanni; Timothy M. de Lorey; JosΓ© M. Serratosa; Anne πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 994 KB
Cortical reflex myoclonus in rett syndro
✍ Dr Renzo Guerrini; Paolo Bonanni; Locio Parmeggiani; Margherita Santucci; Antoni πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 784 KB

## Abstract Rett syndrome (RS) is one of the most frequent causes of mental retardation in females. As there are no known biochemical, genetic, or morphological markers, diagnosis is based on clinical phenotype including severe dementia, autism, truncal ataxia/apraxia, loss of purposeful hand movem

Cortical myoclonus in children
✍ Katsuhiko Oguro; Keiko Oya; Chieko Natori; Hideo Aiba; Hiroatsu Hojo πŸ“‚ Article πŸ“… 2003 πŸ› Elsevier Science 🌐 English βš– 213 KB
Cortical myoclonus in huntington's disea
✍ P. D. Thompson; K. P. Bhatia; P. Brown; M. B. Davis; M. Pires; N. P. Quinn; P. L πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 790 KB

## Abstract We describe three patients with Huntington's disease, from two families, in whom myoclonus was the predominant clinical feature. The diagnosis was confirmed at autopsy in two cases and by DNA analysis in all three. These patients all presented before the age of 30 years and were the off

Effectiveness of piracetam in cortical m
✍ P. Brown; M. J. Steiger; P. D. Thompson; J. C. Rothwell; B. L. Day; M. Salama; T πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 517 KB

## Abstract Twenty‐one patients with disabling spontaneous, reflex, or action myoclonus due to various causes, who had shown apparent clinical improvement on introduction of piracetam, entered a placebo‐controlled double‐blind crossover trial of piracetam (2.4– 16.8 g daily). All but one patient ha